(Q40491603)

21 September 2017

1 reference

title

New cisplatin analogues in development. A review (English)

1 reference

21 September 2017

1 reference

Raymond B Weiss

1

1 reference

21 September 2017

Michaele C Christian

series ordinal

2

1 reference

21 September 2017

publication date

1 September 1993

1 reference

21 September 2017

1 reference

21 September 2017

volume

46

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

360-377

1 reference

Increased cytotoxicity and reversal of resistance to cis-diamminedichloro-platinum(II) with entrapment of cis-Bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) in multilamellar lipid vesicles

21 September 2017

cites work

1 reference

12 December 2020

Cisplatin/carboplatin cross-resistance in ovarian cancer

1 reference

12 December 2020

Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum

1 reference

12 December 2020

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues

1 reference

12 December 2020

Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia

1 reference

12 December 2020

Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.

1 reference

12 December 2020

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

12 December 2020

Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents

1 reference

12 December 2020

Antitumor activity of platinum(II) complexes of 1,2-diamino-cyclohexane isomers

1 reference

12 December 2020

Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)

1 reference

12 December 2020

Ototoxicity of cis-diammine glycolato platinum, 254-S

1 reference

12 December 2020

Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

12 December 2020

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines

1 reference

12 December 2020

The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs

1 reference

12 December 2020

In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplan

1 reference

12 December 2020

Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group study

1 reference

12 December 2020

Antitumor activity and toxicity of cisplatin analogs

1 reference

12 December 2020

The Inhibition of Growth or Cell Division in Escherichia coli by Different Ionic Species of Platinum(IV) Complexes

1 reference

12 December 2020

Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex.

1 reference

12 December 2020

Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues

1 reference

12 December 2020

JMS, successor to cisplatin in advanced ovarian carcinoma?

1 reference

12 December 2020

The successful regression of large solid sarcoma 180 tumors by platinum compounds

1 reference

12 December 2020

Platinum coordination complexes which circumvent cisplatin resistance

1 reference

12 December 2020

Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamminedichloroplatinum(II) on DNA

1 reference

12 December 2020

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

1 reference

12 December 2020

A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer Group.

1 reference

12 December 2020

Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule.

1 reference

12 December 2020

The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).

1 reference

12 December 2020

Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat*1

1 reference

12 December 2020

Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex

1 reference

12 December 2020

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

12 December 2020

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

12 December 2020

Inhibition of brain choline acetyltransferase by tetraplatin

1 reference

12 December 2020

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

12 December 2020

Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential

1 reference

12 December 2020

A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group

1 reference

12 December 2020

Phase I clinical evaluation of [SP-4-3(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butanediamine-N,N1) platinum in patients with metastatic solid tumors

1 reference

12 December 2020

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

Phase III study of DWA2114R for ovarian cancer

1 reference

12 December 2020

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line

1 reference

12 December 2020

A phase I study of DWA2114R

1 reference

12 December 2020

Multicenter phase II study of spiroplatin

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice

1 reference

12 December 2020

Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane

1 reference

12 December 2020

Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1- cyclobutanedicarboxylato(2-)](2 methyl-1,4-butane-diamine-N,N')platinum

1 reference

12 December 2020

The response to chemotherapy of a variety of human tumour xenografts

1 reference

12 December 2020

A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.

1 reference

12 December 2020

Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875)

1 reference

12 December 2020

Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer

1 reference

12 December 2020

Continuous intravenous bleomycin (NSC-125066) therapy with vinblastine (NSC-49842) in stage III testicular neoplasia

1 reference

12 December 2020

Neurotoxic side-effects of cisplatin

1 reference

12 December 2020

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

1 reference

12 December 2020

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

1 reference

12 December 2020

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

1 reference

12 December 2020

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors

1 reference

12 December 2020

Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs

1 reference

12 December 2020

Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer.

1 reference

12 December 2020

Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).

1 reference

12 December 2020

Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.

1 reference

12 December 2020

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

12 December 2020

Cisplatin resistance in human cancers

1 reference

12 December 2020

A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers

1 reference

12 December 2020

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

12 December 2020

Sequence-dependent termination of mammalian DNA polymerase reaction by a new platinum compound, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)-2-plati num(II) monohydrate).

1 reference

12 December 2020

Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice

1 reference

12 December 2020

Circadian timing of cancer chemotherapy

1 reference

12 December 2020

Phase I study of spiroplatin

1 reference

12 December 2020

Circadian rhythm in toxicities and tissue uptake of 1,2-diamminocyclohexane(trans-1)oxalatoplatinum(II) in mice

1 reference

12 December 2020

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

12 December 2020

Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action

1 reference

12 December 2020

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

1 reference

12 December 2020

Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.

1 reference

12 December 2020

cis-diamminedichloroplatinum (II) (cisplatin) alters microtubule assembly dynamics

1 reference

12 December 2020

10.2165/00003495-199346030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1009142328

0 references

1 reference